⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6207167 | 1.00 | — | — | |
| SCHEMBL22931283 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL6206809 | 0.97 | — | — | |
| SCHEMBL11136121 | 0.82 | — | — | |
| SCHEMBL10238446 | 0.82 | — | — | |
| SCHEMBL2872031 | 0.65 | — | — | |
| SCHEMBL17773099 | 0.63 | — | — | |
| SCHEMBL3695688 | 0.62 | — | — | |
| SCHEMBL21676090 | 0.62 | — | — | |
| SCHEMBL3562022 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608811-A1 | PROCESS FOR PREPARING 3-AMINO-1-BUTANOL | Advancion Corporation (US) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024146920-A1 | DRUG CONJUGATES FOR THE TREATMENT OF OCULAR DISORDERS | ASCENDIS PHARMA OPHTHALMOLOGY DIVISION A/S (DK) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024091517-A1 | PROCESS FOR PREPARING 3-AMINO-1-BUTANOL | ADVANCION CORPORATION (US) | 2024-05-02 | — | — | WO | disclosed |
| US-20230340011-A1 | STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS | Asteroid Therapeutics | 2023-10-26 | — | — | US | disclosed |
| US-8039480-B2 | Spirocyclic nitriles as protease inhibitors | SANOFI-AVENTIS (FR) | 2011-10-18 | — | — | US | disclosed |
| US-20090275523-A1 | Spirocyclic nitriles as protease inhibitors | SANOFI-AVENTIS (FR) | 2009-11-05 | — | — | US | disclosed |